CSIMarket
 
Aikido Pharma Inc  (NASDAQ: DOMH)
    Sector  Financial    Industry Investment Services
   Industry Investment Services
   Sector  Financial
 

Aikido Pharma Inc's Customers Performance

DOMH



 
DOMH's Source of Revenues During the corresponding time, Aikido Pharma Inc recorded a revenue increase by 341.38 % year on year, sequentially revenue grew by 19.17 %. While revenue at the Aikido Pharma Inc's corporate clients

List of DOMH Customers




for the same period Aikido Pharma Inc recorded revenue increase by 341.38 % year on year, sequentially revenue grew by 19.17 %.

List of DOMH Customers

Aikido Pharma Inc's Business Units






Aikido Pharma Inc's Comment on Sales, Marketing and Customers



Dominari Securities provides services to investors in the equities market through equity derivatives and index options strategies. The company offers institutional fixed income sales and trading in public and private debt securities, including sovereign, investment-grade, non-investment-grade, distressed, and convertible corporate securities. It also engages in securities lending to brokers and dealers. Dominari Securities' asset management services cater to high-net-worth private clients, institutions, corporations, and their sponsored plans, offering discretionary and non-discretionary fee-based investment management solutions such as portfolio management, manager research, asset allocation advice, and financial planning. Its asset management products include separately managed accounts, discretionary advisory accounts, and non-discretionary advisory accounts. The company generates revenue from investment advisory and transactional fees, as well as revenue-sharing arrangements with registered and private alternative investment vehicles.





Aikido Pharma Inc’s Comment on Sales, Marketing and Customers


Dominari Securities provides services to investors in the equities market through equity derivatives and index options strategies. The company offers institutional fixed income sales and trading in public and private debt securities, including sovereign, investment-grade, non-investment-grade, distressed, and convertible corporate securities. It also engages in securities lending to brokers and dealers. Dominari Securities' asset management services cater to high-net-worth private clients, institutions, corporations, and their sponsored plans, offering discretionary and non-discretionary fee-based investment management solutions such as portfolio management, manager research, asset allocation advice, and financial planning. Its asset management products include separately managed accounts, discretionary advisory accounts, and non-discretionary advisory accounts. The company generates revenue from investment advisory and transactional fees, as well as revenue-sharing arrangements with registered and private alternative investment vehicles.








DOMH's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Aikido Pharma Inc 38.49 128.83 53.92 36
SUBTOTAL 0.00 0.00 0.00 -

Sources: Aikido Pharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Aikido Pharma Inc’s corporate clients.
For your research, we’ve provided 9 tables on Aikido Pharma Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.